SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Ride the Tiger with CD

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: skinowski who wrote (278512)4/16/2020 5:02:45 PM
From: ajtj99  Read Replies (2) of 312621
 
Without knowing the demographic makeup, health, and weights of Zelenko's patients, it's hard to know the effectiveness of HCQ on his patients relative to other treatments, IMO.

The one place we know that has done antibody studies in Germany shows about a 0.39% death rate in that hot spot. Zelencko's is about half of that. How much is due to demographics, health, and weights of his patients? Also, do his patients vape or have a history of having done so? Vaping is thought to be a major factor in hospitalizations for younger patients.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext